Gaballa, Sameh

Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant. [electronic resource] - American journal of hematology 10 2016 - E442-7 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural

1096-8652

10.1002/ajh.24487 doi


Adult
Aged
Disease Progression
Disease-Free Survival
Female
Gene Deletion
Hematopoietic Stem Cell Transplantation--methods
Humans
Immunologic Factors--therapeutic use
Male
Middle Aged
Multiple Myeloma--genetics
Proteasome Inhibitors--therapeutic use
Recurrence
Survival Analysis
Transplantation, Autologous
Treatment Outcome
Tumor Suppressor Protein p53--genetics